More Business Wire
View Older Stories View Newer Stories-
Churchill’s Anne Philpott Named to WSJ Pro Private Equity’s 2024 Women To Watch List
-
Cotiviti to Launch End-to-End Healthcare Fraud Solution at 2024 NHCAA Annual Training Conference
-
DigitalOwl Announces Strategic Collaboration with ExamOne to Improve Record Retrieval and Analysis
-
ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
-
Esperanto Technologies and NEC Cooperate on Initiative to Advance Next Generation RISC-V Chips and Software Solutions for HPC
-
AMP to Operate Waste Connections Recycling Facility with AI-Powered Sortation Technology
-
Avenacy Announces Launch of Dexmedetomidine Injection, USP in the U.S. Market
-
BridgeBio Oncology Therapeutics (BBOT) Appoints Praveen Tipirneni, MD, to its Board of Directors as Non-Executive Director
-
Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
-
Media Release: Following a year of elections held worldwide, Allianz launches global “Power of Unity” program to reinforce the strength of common ground
-
Take Control of Your Heart Health: No-Cost Health Screenings Including Lp(a) Testing Offered in Clarkston by Care Access
-
Deluxe Announces Senior Secured Notes Offering
-
DocGo Announces Participation at Three Upcoming Investor Conferences
-
Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
-
Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
-
Almonty Industries Inc. Appoints Fernando Vitorino as Chief Operating Officer of Almonty Korea Tungsten Corp. (“AKTC”)
-
Vertiv Hosts Investor Event and Announces Quarterly Dividend
-
Capstan Therapeutics Presents Preclinical Data on Lead In Vivo CAR-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
-
Odyssey Investment Partners Sells NSI Industries
-
Generate Capital Welcomes Harsi Thethi as Interim CFO, Recognizing Brian Lehman’s Impact
-
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
-
SkyWater Announces Participation in 13th Annual NYC Summit
-
Pacific Defense Announces Expansion of Manufacturing and Design Engineering Center in Sunnyvale, CA to Meet Growing Global Demand
-
Kinaxis Launches Supply Chain Orchestration Maturity Model and Self-Assessment
-
FiscalNote Announces Generative AI Distribution Partnership With AI Search Engine ProRata.ai to License FiscalNote’s Award-Winning, Trusted Content
-
Advyzon Announces Auria, New Product Offering for Family Offices and UHNW Clients
-
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
-
Deluxe Announces Inducement Grant for Kimberly Cross
-
CI Global Asset Management Announces Mutual Fund and ETF Mergers and a Risk Rating Change
-
SBC Medical Group Holdings Announces Definitive Agreement to Acquire, Aesthetic Healthcare Holdings Pte. Ltd, a Multi-Unit Owner of Aesthetic Treatment Clinics in Singapore
-
Alentis Receives FDA Fast Track Designation for ALE.P02 for the Treatment of CLDN1+ Squamous Solid Tumors
-
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
-
Bruker Announces Quarterly Dividend
-
Rockwell Automation Kicks Off Automation Fair® 2024 to Inspire Global Innovation and Industry Transformation
-
Ecore Secures Strategic Investment from General Atlantic’s BeyondNetZero Fund to Accelerate Circularity and Net-Zero Initiatives
-
Kobo Resources Extends Highly Prospective Jagger Zone by 250 m South with Strong New Gold Intercepts, Including 7.0 m at 3.66 g/t Au and 4.0 m at 3.26 g/t Au
-
Corsair Gaming to Present at 2024 UBS Global Technology Conference
-
U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® (tepotinib) to Identify Patients with MET Exon 14 Skipping Alterations in Non-Small Cell L
-
Old Dominion Freight Line, Inc. Announces General Rate Increase
-
Canadian Girls’ Sport Participation on the Rise but Still Lags Behind Boys, According to New Research
-
MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer
-
Wolfspeed Announces Leadership Transition
-
Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
-
Pantheon Expands Global Private Wealth Platform Offerings With Launch of Secondaries-focused Evergreen Funds in US and Australia
-
Roots Celebrates Thoughtfulness in Holiday Pop-Up
-
monday.com Announces Participation in the 51st Nasdaq London Investor Conference
-
PERENfra Signs Water and Wastewater Service Agreement with Harris County Municipal Utility District No. 586
-
Revisto Raises $4 Million in Seed Funding to Revolutionize Pharmaceutical Marketing Compliance with AI
-
Alphind healthcare Launches APAC HQ to Accelerate Healthy Ageing
-
ECS-CMS Team Receives Agency Honor Award
